Register Now

Monday, 23 April 2018

Welcome Refreshments (wine, soft drinks, and hors d'oeuvres) & Registration
16:00 – 16:30
CME Symposium / Q&A Session
16:30 – 18:00

IFEMA - Feria de Madrid
Hall K
Avda. Del Partnon 5
28042 Madrid, Spain

16:00 – 16:30 Welcome Refreshments (wine, soft drinks, and hors d'oeuvres) & Registration
16:30 – 16:35 Welcome and Introductions
  Mario Fernández-Ruiz, MD, PhD
16:35 – 16:50 CMV in Transplant: Unmet Needs in Detection, Prevention, Prophylaxis, and Management
  Mario Fernández-Ruiz, MD, PhD
16:50 – 17:10 Update on Current Management of CMV in Transplant Patients
  Atul Humar, MD, MSc, FRCP(C)
17:10 – 17:30 Emerging Therapies for CMV in Transplant Patients
  Roy F. Chemaly, MD, MPH, FACP, FIDSA
17:30 – 18:00 Clinical Cases, Panel Discussion, and Audience Q&A
  All Faculty


Mario Fernández-Ruiz, MD, PhD (Chair)
Unit of Infectious Diseases
University Hospital "12 de Octubre"
Madrid, Spain

Atul Humar, MD, MSc, FRCP(C)
Director, Transplant Program
University Health Network
Toronto, ON (Canada)

Roy F. Chemaly, MD, MPH, FACP, FIDSA
Professor of Medicine
Director, Infection Control Section
Director, Clinical Virology Research
Department of ID/IC/EH
UT MD Anderson Cancer Center
Houston, TX (USA)

This activity has been designed to meet the educational needs of clinicians who manage cytomegalovirus (CMV) infection in transplant patients.

After participating in this educational activity, participants should be better able to:

  • Implement prophylactic and preventive anti-CMV therapy in at-risk transplant patients as recommended by the current evidence base
  • Promptly diagnose transplant patients with CMV infection and disease, using new and emerging assays and tools
  • Apply clinical trial data for new and emerging treatment options to manage transplant patients infected with CMV, including those with resistant or refractory disease
  • Identify and address adverse events of agents used for prophylaxis and treatment of CMV infection and disease

An application has been made to the UEMS EACCME® for CME accreditation of this event.

It is the policy of RMEI Medical Education, LLC and AKH Inc., Advancing Knowledge in Healthcare, to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by RMEI and AKH prior to accreditation of the activity and may include any of, or a combination of, the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence supports the recommendation; moderator review; and peer review. AKH planners and reviewers have no relevant financial relationships to disclose.

There is no fee for this educational activity.

Jointly provided by AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC.

Register Now

This educational activity is supported by an independent medical educational grant from Shire.



Facebook Twitter

Additional educational activities offered by RMEI Medical Education, LLC can be found at or by calling toll-free (866) 770-RMEI.